Chiara Donini - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Chiara Donini

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

International Journal of Molecular Sciences|September 23, 2022

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GISTErika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2020

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma HistotypesValeria Leuci, Chiara Donini, Giovanni Grignani, et al.

Journal of Experimental & Clinical Cancer Research : CR|November 23, 2023

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanomaLidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer CellsRamona Rotolo, Valeria Leuci, Chiara Donini, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

International Journal of Molecular Sciences|September 23, 2022

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GISTErika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2020

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma HistotypesValeria Leuci, Chiara Donini, Giovanni Grignani, et al.

Journal of Experimental & Clinical Cancer Research : CR|November 23, 2023

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanomaLidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer CellsRamona Rotolo, Valeria Leuci, Chiara Donini, et al.

Pageof 2